Dose-Related Reductions In Blood Pressure With A Rna Interference (Rnai) Therapeutic Targeting Angiotensinogen In Hypertensive Patients: Interim Results From A First-In-Human Phase 1 Study Of Aln-Agt01
Circulation(2020)
Abstract
Background: Angiotensinogen (AGT) is the sole precursor of all angiotensin peptides and plays a key role in hypertension pathogenesis. We evaluated the effect of ALN-AGT01, a subcutaneous investiga...
MoreTranslated text
Key words
therapeutic targeting angiotensinogen,hypertensive patients,rna interference,blood pressure,rnai,dose-related,first-in-human,aln-agt
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined